Stablepoint Partners’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.75M Buy
67,921
+443
+0.7% +$35.7K 0.8% 46
2026
Q1
$4.77M Buy
67,478
+7,477
+12% +$560K 0.71% 50
2025
Q4
$4.74M Sell
60,001
-1
-0% -$79 0.74% 50
2025
Q3
$4.94M Buy
60,002
+6,569
+12% +$517K 0.78% 47
2025
Q2
$4.3M Buy
53,433
+1,400
+3% +$108K 0.73% 49
2025
Q1
$4.18M Sell
52,033
-5,284
-9% -$439K 0.76% 51
2024
Q4
$4.69M Buy
57,317
+247
+0.4% +$20.6K 0.86% 36
2024
Q3
$4.71M Sell
57,070
-77
-0.1% -$5.75K 0.86% 41
2024
Q2
$4.31M Sell
57,147
-9,818
-15% -$701K 0.84% 46
2024
Q1
$4.96M Buy
66,965
+4,261
+7% +$297K 1.01% 34
2023
Q4
$4.15M Buy
+62,704
New +$3.92M 1.06% 35

Other funds holding MET

Stablepoint Partners's MET Position: Q2 2026 in Review

Stablepoint Partners increased its MetLife (MET) stake by 0.66% in Q2 2026, buying an estimated $35.7K and bringing the position to 67,921 shares worth $5.75M. The position accounts for 0.8% of the portfolio, ranked #46.

Stablepoint Partners first reported a position in MET in Q4 2023 and has held it in 11 quarters since. 1,445 funds tracked by Wall St. Rank hold MET as of Q2 2026.

  • Stablepoint Partners held 67,921 shares of MetLife worth $5.75M as of Q2 2026.
  • Stablepoint Partners bought 443 MetLife shares in Q2 2026, an estimated $35.7K.
  • MetLife made up 0.8% of Stablepoint Partners's portfolio in Q2 2026, its #46 holding.
  • Stablepoint Partners first reported a position in MetLife in Q4 2023 and has held it in 11 quarters since.
  • 1,445 funds tracked by Wall St. Rank held MetLife as of Q2 2026.

Based on Stablepoint Partners's 13F filing for Q2 2026, filed 9 Jul 2026.